Ellen Karasik

17.1k total citations
22 papers, 361 citations indexed

About

Ellen Karasik is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Ellen Karasik has authored 22 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Cell Biology. Recurrent topics in Ellen Karasik's work include Epigenetics and DNA Methylation (8 papers), Prostate Cancer Treatment and Research (7 papers) and Hemoglobin structure and function (4 papers). Ellen Karasik is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Prostate Cancer Treatment and Research (7 papers) and Hemoglobin structure and function (4 papers). Ellen Karasik collaborates with scholars based in United States, Italy and United Kingdom. Ellen Karasik's co-authors include Bryan M. Gillard, Barbara A. Foster, Dominic J. Smiraglia, Michael T. Moser, Gaia Bistulfi, Hayley C. Affronti, Sebastiano Battaglia, James G. Phillips, Carl Morrison and Laura D. Kwiatkowski and has published in prestigious journals such as Nature Communications, PLoS ONE and Biochemistry.

In The Last Decade

Ellen Karasik

22 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Karasik United States 11 207 63 59 59 50 22 361
Daniel LaSala United States 11 202 1.0× 75 1.2× 50 0.8× 35 0.6× 50 1.0× 17 454
Daniel Mathow Germany 9 174 0.8× 27 0.4× 44 0.7× 46 0.8× 48 1.0× 11 348
Michihiro Sakai Japan 9 290 1.4× 31 0.5× 53 0.9× 50 0.8× 63 1.3× 20 488
Meng Wu China 13 374 1.8× 47 0.7× 57 1.0× 68 1.2× 33 0.7× 21 473
Joshua Ogony United States 9 178 0.9× 41 0.7× 108 1.8× 77 1.3× 15 0.3× 14 357
Xuxia Wu Sweden 13 209 1.0× 35 0.6× 28 0.5× 49 0.8× 71 1.4× 17 487
Mei-Shiue Kuo France 8 371 1.8× 98 1.6× 83 1.4× 42 0.7× 36 0.7× 11 483
Mike Z. Lin Australia 11 305 1.5× 45 0.7× 97 1.6× 116 2.0× 48 1.0× 13 475
Jeanine Traag United States 4 222 1.1× 27 0.4× 93 1.6× 69 1.2× 20 0.4× 4 356
Waleed Al-Ali Kuwait 9 273 1.3× 25 0.4× 68 1.2× 41 0.7× 98 2.0× 15 409

Countries citing papers authored by Ellen Karasik

Since Specialization
Citations

This map shows the geographic impact of Ellen Karasik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Karasik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Karasik more than expected).

Fields of papers citing papers by Ellen Karasik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Karasik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Karasik. The network helps show where Ellen Karasik may publish in the future.

Co-authorship network of co-authors of Ellen Karasik

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Karasik. A scholar is included among the top collaborators of Ellen Karasik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Karasik. Ellen Karasik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gillard, Bryan M., Ellen Karasik, Edward Hurley, et al.. (2023). Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation. iScience. 26(11). 108303–108303. 8 indexed citations
2.
Gillard, Bryan M., Michelle Wrobel, Ellen Karasik, et al.. (2023). Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer. Frontiers in Oncology. 13. 1120329–1120329. 4 indexed citations
3.
Want, Muzamil Y., Ellen Karasik, Bryan M. Gillard, AJ Robert McGray, & Sebastiano Battaglia. (2021). Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer. International Journal of Molecular Sciences. 22(16). 8742–8742. 8 indexed citations
4.
Want, Muzamil Y., Takemasa Tsuji, Prashant Kumar Singh, et al.. (2021). WHSC1/NSD2 regulates immune infiltration in prostate cancer. Journal for ImmunoTherapy of Cancer. 9(2). e001374–e001374. 27 indexed citations
5.
Affronti, Hayley C., Aryn M. Rowsam, Spencer R. Rosario, et al.. (2020). Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy. Nature Communications. 11(1). 52–52. 46 indexed citations
6.
Chen, Ruidong, Xin Liang, Ellen Karasik, et al.. (2020). A simple quantitative PCR assay to determine TRAMP transgene zygosity. Prostate Cancer and Prostatic Diseases. 24(2). 358–361. 1 indexed citations
7.
Mett, Vadim, Elena A. Komarova, Ivan A. Bespalov, et al.. (2017). Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy. Oncogene. 37(4). 439–449. 33 indexed citations
8.
Battaglia, Sebastiano, Ellen Karasik, Bryan M. Gillard, et al.. (2017). LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer. Clinical Epigenetics. 9(1). 82–82. 18 indexed citations
9.
Affronti, Hayley C., Mark D. Long, Spencer R. Rosario, et al.. (2017). Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model. Oncotarget. 8(61). 103758–103774. 11 indexed citations
10.
Karasik, Ellen, et al.. (2017). miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth. Oncotarget. 8(40). 67626–67638. 10 indexed citations
11.
Bistulfi, Gaia, Hayley C. Affronti, Barbara A. Foster, et al.. (2016). The essential role of methylthioadenosine phosphorylase in prostate cancer. Oncotarget. 7(12). 14380–14393. 31 indexed citations
12.
Affronti, Hayley C., Ellen Karasik, Bryan M. Gillard, et al.. (2015). Metastatic phenotype in CWR22 prostate cancer xenograft following castration. The Prostate. 76(4). 359–368. 7 indexed citations
13.
Kirk, Jason, Ellen Karasik, Bryan M. Gillard, et al.. (2014). Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer. PLoS ONE. 9(2). e89555–e89555. 26 indexed citations
14.
Bistulfi, Gaia, Barbara A. Foster, Ellen Karasik, et al.. (2011). Dietary Folate Deficiency Blocks Prostate Cancer Progression in the TRAMP Model. Cancer Prevention Research. 4(11). 1825–1834. 35 indexed citations
15.
Kinney, Shannon R. Morey, Wa Zhang, Marién Pascual, et al.. (2009). Lack of Evidence for Green Tea Polyphenols as DNA Methylation Inhibitors in Murine Prostate. Cancer Prevention Research. 2(12). 1065–1075. 31 indexed citations
16.
Cowell, John K., Karen Head, Padmaja Kunapuli, et al.. (2009). Inactivation of LGI1 expression accompanies early stage hyperplasia of prostate epithelium in the TRAMP murine model of prostate cancer. Experimental and Molecular Pathology. 88(1). 77–81. 6 indexed citations
17.
18.
19.
Kwiatkowski, Laura D., et al.. (2004). Ligand Binding to Symmetrical FeZn Hybrids of Variants of Human HbA with Modifications in the α1−β2 Interface. Biochemistry. 43(24). 7843–7850. 7 indexed citations
20.
Samuni, Uri, Laura J. Juszczak, David Dantsker, et al.. (2003). Functional and Spectroscopic Characterization of Half-Liganded Iron−Zinc Hybrid Hemoglobin:  Evidence for Conformational Plasticity within the T State ,. Biochemistry. 42(27). 8272–8288. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel LaSala Breakdown of academic impact, for papers by Daniel Mathow Breakdown of academic impact, for papers by Michihiro Sakai Breakdown of academic impact, for papers by Meng Wu Breakdown of academic impact, for papers by Joshua Ogony Breakdown of academic impact, for papers by Xuxia Wu Breakdown of academic impact, for papers by Mei-Shiue Kuo Breakdown of academic impact, for papers by Mike Z. Lin Breakdown of academic impact, for papers by Jeanine Traag Breakdown of academic impact, for papers by Waleed Al-Ali
Rankless by CCL
2026